CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 424B2 Offering Prospectus
- 8-K Event Material agreement
- 4 Open-market buy Vice President Clinical Develo bought 400 shares at $4.50 ($1,800)
- 4 Open-market buy Chief Financial Officer bought 1,850 shares at an average $5.08 ($9,393)
- 4 Open-market buy Vice President Asia Pacific bought 1,100 shares at $4.17 ($4,587)
- 4 Open-market buy Vice President Clinical Devel bought 800 shares at an average $5.15 ($4,120)
- 4 Open-market buy Chief Financial Officer bought 2,300 shares at an average $5.37 ($12,341)
- 8-K Event Other events
- 4 Open-market buy Chief Financial Officer bought 1,550 shares at an average $5.31 ($8,236)
- 4 Open-market buy Chief Financial Officer bought 1,600 shares at an average $5.09 ($8,152)
- 4 Open-market buy Chief Financial Officer bought 1,700 shares at an average $4.45 ($7,563)
- 4 Open-market buy Vice President Asia Pacific bought 1,100 shares at $4.76 ($5,236)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at an average $4.40 ($10,988)
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 4 Open-market buy 10% owner bought 1,913,043 shares at $5.75 ($10,999,997)
- 424B2 Offering Prospectus
- 424B2 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 8-K Event Other events
Page 63 of 74 · 1,465 filings